Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Repare Therapeutics
450 Kendall St
Cambridge, MA 02142
http://www.reparerx.com/

Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality. Repare's platform combines a proprietary, high-throughput, CRISPR-enabled gene editing target discovery method with high-resolution protein crystallography, computational biology and clinical informatics.

Key Contact
Name
Lloyd M. Segal
Title
President & CEO
Funding Events

Date
Amount
Type
Investors
Valuation
06/22/17 $68,000,000 Series A BDC Capital Healthcare Venture Fund
Celgene Corporation
Fonds de solidarite FTQ
MPM Capital
Versant Ventures
undisclosed
09/05/19 $82,500,000 Series B BDC Capital Healthcare Venture Fund
BVF Partners
Cowen Healthcare Investments
Fonds de solidarite FTQ
Logos Capital
MPM Capital
OrbiMed US
Redmile Group
Versant Ventures
undisclosed